ArticleUse and Toxicity of Checkpoint Inhibitors for Solid Tumor Treatment in a Veteran PopulationAuthor:William E. Bryan III, PharmD, BCPSPublish date: August 25, 2021Incidence of immune-related adverse events was not impacted by dosing strategy for PD-1 inhibitors but may provide cost savings.Read More
